Substance Use Disorders and Tobacco Habits

Overview

In the department for substance use disorders at Uppsala University Hospital there are two wards. One that is locked, where the patients that are emitted can not go out to smoke and another ward where there is a possibility to go out and smoke during the day. The smoking habits on those two floors will be compared and how they feel about smoking will be evaluated when they are admitted to the ward, at discharge, after 1 mont and after 6 months.

Full Title of Study: “Tobacco Habits and the Ability to Quit Smoking Among Patients With Substance Use Disorders”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Non-Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: October 2018

Detailed Description

In the department for substance use disorders at Uppsala University Hospital there are two wards. One that is locked, where the patients that are emitted can not go out to smoke and another ward where there is a possibility to go out and smoke during the day. The smoking habits on those two wards will be compared and how they feel about smoking will be evaluated when they are admitted to the ward, at discharge, after 1 mont and after 6 months. The questionnaires that will be used for evaluation are: Fagerstöms test for nicotine dependence, Alcohol Use Disorders Identification Test and Drug Use Disorders Identification Test and the symptoms of Tobacco withdrawal mentioned in DSM-V. Parameters that will be measured are: pulse, bloodpressure, peak expiratory flow, wight and height. There will also be some questions about their smoking and snuff habits, if they have tried to quite smoking Before and how they were affected by the stop.

Interventions

  • Other: No smoking
    • No smoking
  • Other: Smoking
    • Ability to go out to smoke

Arms, Groups and Cohorts

  • Active Comparator: No smoking
    • The ward where the patients can not go out to smoke
  • Placebo Comparator: Smoking
    • The ward where the patients can go out to smoke.

Clinical Trial Outcome Measures

Primary Measures

  • Less smoking
    • Time Frame: From baseline to 1 month
    • Number of cigarettes /day
  • Less smoking
    • Time Frame: From baseline to 6 month
    • Number of cigarettes /day

Secondary Measures

  • withdrawal symptoms
    • Time Frame: From baseline to emitted from the ward aproximately 1 week
    • Blood pressure, Worry, nausea e.t.c.
  • withdrawal symptoms
    • Time Frame: From baseline to 1 month
    • Blood pressure, Worry, nausea e.t.c.
  • withdrawal symptoms
    • Time Frame: From baseline to 6 month
    • Blood pressure, Worry, nausea e.t.c.
  • Thought about not smoking any more
    • Time Frame: From baseline to emitted from the ward aproximately 1 week
    • Questions
  • Thought about not smoking any more
    • Time Frame: From baseline to 1 month
    • Questions
  • Thought about not smoking any more
    • Time Frame: From baseline to 6 month
    • Questions
  • PEF
    • Time Frame: From baseline to emitted from the ward aproximately 1 week
    • Improved expiratory flow
  • PEF
    • Time Frame: From baseline too 1 month
    • Improved expiratory flow
  • PEF
    • Time Frame: From baseline to 6 month
    • Improved expiratory flow
  • Weight
    • Time Frame: From baseline to emitted from the ward aproximately 1 week
    • Changes in weight
  • Weight
    • Time Frame: From baseline to 1 month
    • Changes in weight
  • Weight
    • Time Frame: From baseline to 6 month
    • Changes in weight

Participating in This Clinical Trial

Inclusion Criteria

Substance use disorder - Exclusion Criteria:

Disorganization, psychosis and if you can not speak Swedish. -

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 85 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Uppsala University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Katarina Danielsson, Medical Doctor, Doctor of Philosphy (Faculty of Medicine) – Uppsala University
  • Overall Official(s)
    • Katarina Danielsson, MD, PhD, Principal Investigator, Uppsala University Hospital
  • Overall Contact(s)
    • Katarina Danielsson, MD, PhD, 0046186112173, katarina.danielsson@akademiska.se

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.